Supplementary Figure S3 from Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non–Small Cell Lung Cancer

2026 Open access

Read full text
Authors: Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal, J.L. González-Larriba, Alex Martínez‐Martí, Reyes Bernabé, Joaquim Bosch‐Barrera, Virginia Calvo, Amelia Insa Molla, Noemí Reguart, Javier de Castro, Carlos Aguado
+10 more Ramón Palmero, Florentino Hernándo, Javier Martín-López, Alejandro Rodríguez-Festa, Pilar Mediavilla-Medel, Martín Lázaro, Jim Hayes, Alberto Cruz‐Bermúdez, Bartomeu Massutí, Atocha Romero
DOI: 10.1158/1078-0432.31353257
Cited by: 0

Abstract

Supplementary figure 3. Incremental prognostic value of MRD status beyond pathological response in multivariable models. Likelihood ratio (LR) tests show the added predictive contribution of MRD (defined as detection in at least two samples) when incorporated into models including pathological response for (A) event-free survival (EFS) and (B) overall survival (OS). P values from likelihood ratio tests are indicated above each plot.

Fields of Study & Subjects

Lung Cancer Diagnosis and Treatment Lung Cancer Treatments and Mutations Lung Cancer Research Studies

Publication details

Publication date
17 February 2026
Language
EN